Grazia Aleppo, MD, discusses the evolving role of continuous glucose monitoring (CGM) in non-insulin-treated Type 2 diabetes, drawing from her recent review published in Diabetes Technology and Therapeutics that examines evolving evidence and real world implications.Practical considerations for integrating CGM into routine care are also reviewed, with an emphasis on early intervention and data-driven decision-making.Key Topics• Evidence supporting CGM use in non-insulin-treated type 2 diabetes • Limitations of A1C and the role of time in range • Impact of CGM on patient engagement and self-management • Clinical and real-world outcomes associated with CGM adoption • Practical applications for endocrinology and primary careLearn more about Northwestern Medicine Endocrinology
